Risk Management (Risk Management Activities) (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Derivative Instruments, Gain (Loss) [Line Items]
Product revenues	$ 84.7	$ 129.4	$ 395.7	$ 296.9
Commodity contract
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative instruments not designated as hedging	$ 45.0	$ (53.4)	$ (6.3)	$ (94.8)

Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4CC
-URI https://asc.fasb.org/extlink&oid=125515794&loc=SL109998890-113959

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4C
-Subparagraph (e)
-URI https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959

Name:	us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration